“Understanding Mechanisms of Resistance and Augmenting Response to Melanoma Immunotherapy”
Peter Prieto, M.D., M.P.H., C.M.Q.
Assistant Professor, Division of Surgical Oncology
Associate Program Director for Research, Surgical Residency Program
Co-Director, Translational Science Core
Director, Tissue Bank
James P. Wilmot Cancer Institute
University of Rochester Medical Center
Dr. Prieto is triple board certified in complex general surgical oncology, general surgery and medical quality. As a fully trained tumor immunotherapist and surgical oncologist, he has expertise in the treatment of primary, regionally advanced and metastatic melanoma, soft tissue sarcoma and breast cancer. His research interests and laboratory investigate mechanisms of immune evasion by solid tumors to targeted and immune checkpoint blockade and prognostic markers of response to immune based therapies including adoptive cell therapy (including melanoma, sarcoma, cholangiocarcinoma and breast cancer).
Monday, April 1, 2019 at 12:00pm to 1:00pm
School of Medicine and Dentistry, Upper Auditorium (3-7619)
415 Elmwood Ave, Rochester, NY 14642